Vertex Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $962.6M | $2.32B | $569.3M |
| FY2014 | $1.24B | $2.33B | $625.3M |
| FY2015 | $1.40B | $2.50B | $714.8M |
| FY2016 | $1.56B | $2.90B | $1.18B |
| FY2017 | $1.50B | $3.55B | $1.67B |
| FY2018 | $1.81B | $3.56B | $2.65B |
| FY2019 | $2.23B | $6.26B | $3.11B |
| FY2020 | $3.07B | $11.75B | $5.99B |
| FY2021 | $3.33B | $13.43B | $6.80B |
| FY2022 | $4.24B | $18.15B | $10.50B |